BioPharma

Why would pharma companies be OK with a Rose Garden event celebrating a $150 billion deal but then balk at a Rose Garden event that included the $100 cards?

Allergan PLC defeated a proposed class action by employees who said they lost retirement savings because of the company’s participation in a generic drug price-fixing scheme.

Despite the announcements, the EOs are likely to face significant implementation challenges, as they would have to go through a lengthy rule-making process and many details are missing, making a complete assessment impossible.

New York state filed civil charges on Thursday accusing Johnson & Johnson of insurance fraud for downplaying the risks of opioid painkillers, including to doctors and elderly patients.

Contributions Of Public Health, Pharmaceuticals, And Other Medical Care To US Life Expectancy Changes, 1990-2015

Cancer drugs in the U.S. routinely cost $10,000 a month. Even prices for old drugs have spiked.

How a Monopoly on Remdesivir Led to Rationing

A market Study.

Adopting a through-cycle approach to deal making in the wake of the COVID-19 pandemic can position pharmaceutical companies for greater success in the next normal.

Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease.

Insiders from at least 11 companies with vaccine announcements sold over $1 billion of shares just from March through late July.

U.S. appeals court upheld a controversial New York state law to require drug makers and distributors to fund a program for covering costs for treatment, prevention, and recovery related to the opioid crisis.

Big drug companies don't need more subsidies. We need to end their greed." —Sen. Bernie Sanders.

Valuations are fundamental information about any startup.

“This is really not the right way to go,” Bill Anderson, the Swiss company’s pharmaceuticals division CEO, said on a call with investors.